PNEUMOCYSTIS JIROVECI PNEUMONIA
Clinical trials for PNEUMOCYSTIS JIROVECI PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS JIROVECI PNEUMONIA trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECI PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could steroids slash death rates from a rare, deadly pneumonia?
Disease control Not yet recruitingThis study tests whether adding corticosteroids to standard care can lower the high death rate (60-80%) of severe Pneumocystis pneumonia in people with weakened immune systems (not from HIV). About 240 ICU patients will receive either standard care alone or standard care plus dif…
Matched conditions: PNEUMOCYSTIS JIROVECI PNEUMONIA
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Could shorter steroid courses be safer for severe pneumonia patients?
Disease control Not yet recruitingThis study looks at how long adults with severe Pneumocystis pneumonia (a serious lung infection) should take steroids. People who get better quickly (no longer need oxygen by day 10) will either stop steroids then or continue for 21 days. The goal is to see if stopping earlier r…
Matched conditions: PNEUMOCYSTIS JIROVECI PNEUMONIA
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 19, 2026 12:00 UTC